These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6352611)

  • 1. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():1-8. PubMed ID: 6352611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam in patients with acute purulent exacerbations of chronic bronchitis: failure to prevent emergence of pneumococcal infections.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1985 Mar; 15(3):375-84. PubMed ID: 3922936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP
    J Antimicrob Chemother; 1984 Dec; 14(6):653-60. PubMed ID: 6097574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is treatment of acute exacerbations of chronic bronchitis with intramuscular mezlocillin justifiable?
    Maesen FP; Davies BI; Brouwers J; Salemans T
    J Antimicrob Chemother; 1983 Aug; 12(2):169-73. PubMed ID: 6604723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B; Malmborg AS; Alfredson H; Ericsson A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pefloxacin in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP
    J Antimicrob Chemother; 1985 Sep; 16(3):379-88. PubMed ID: 3863811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children.
    Rappaz I; Decosterd LA; Bille J; Pilet M; Bélaz N; Roulet M
    Eur J Pediatr; 2000 Dec; 159(12):919-25. PubMed ID: 11131352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latamoxef (moxalactam) in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Brouwers J; Salemans T; Nelissen-Wamper M; Debruyne H
    J Antimicrob Chemother; 1983 Feb; 11(2):115-23. PubMed ID: 6219980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temafloxacin in acute purulent exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Gubbelmans HL; Cremers HM
    J Antimicrob Chemother; 1990 Aug; 26(2):237-46. PubMed ID: 2120178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephazolin in severe purulent exacerbations of chronic bronchitis. Preliminary study.
    Pines A; Nandi AR; Raafat H; Rahman
    Chemotherapy; 1977; 23(2):114-20. PubMed ID: 832548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa.
    Maslow MJ; Rosenberg A; Pollock AA; Press RA; Silverman D; El-Sadr W; Richmond AS; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():213-7. PubMed ID: 6413486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study.
    Davies BI; Maesen FP; Gubbelmans R
    J Antimicrob Chemother; 1989 May; 23(5):743-51. PubMed ID: 2547747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic and diagnostic contribution of ceftazidime (Fortum) in Pseudomonas aeruginosa superinfection in a patient with chronic bronchopathy].
    Mihălţan F; Ulmeanu R; Ciprut T; Dragoş M
    Pneumoftiziologia; 1997; 46(1):53-7. PubMed ID: 9289238
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime in the treatment of chronic suppurative otitis media in children.
    Lautala P; Vare M; Vuorinen O; Kaar ML
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():365-7. PubMed ID: 6352646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis.
    Tsang KW; Chan WM; Ho PL; Chan K; Lam WK; Ip MS
    Eur Respir J; 1999 Nov; 14(5):1206-9. PubMed ID: 10596714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological evaluation of pefloxacin in lower respiratory tract infections.
    Tatsis G; Tsoukalas G; Hatzinikolaou V; Boulbasakos G; Jordanoglou J
    J Int Med Res; 1996; 24(6):478-81. PubMed ID: 8959532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
    Clumeck N; Gordts B; Dab I; Jaspar N; Van Laethem Y; Butzler JP
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():207-11. PubMed ID: 6352620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.